These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22338197)

  • 1. [Evaluation of chlorambucil in CLL: better late than never].
    Delarue R
    Rev Prat; 2011 Nov; 61(9 Suppl):S3-4. PubMed ID: 22338197
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine versus chlorambucil: is the debate over?
    Rai KR; Hollweg A
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary acute leukemia in chronic lymphocytic leukemia.
    Grünwald HW; Rosner F
    N Engl J Med; 1998 Sep; 339(13):924. PubMed ID: 9750094
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia in the elderly population.
    Rai KR
    Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
    Vidal L; Gurion R; Ram R; Raanani P; Bairey O; Robak T; Gafter-Gvili A; Shpilberg O
    Leuk Lymphoma; 2016 Sep; 57(9):2047-57. PubMed ID: 26980554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia.
    Goede V; Eichhorst B; Fischer K; Wendtner CM; Hallek M
    Leuk Lymphoma; 2015 Jun; 56(6):1585-92. PubMed ID: 25219593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chlorambucil on B-lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia--study of cellular ultrastructure].
    Brajusković G; Marjanović S; Skaro-Milić A
    Vojnosanit Pregl; 2003; 60(2):175-80. PubMed ID: 12852160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do drugs work in CLL?
    Plunkett W; Begleiter A; Liliemark JO; Reed JC
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():1-11. PubMed ID: 9021705
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards improved frontline treatment of CLL in the elderly.
    Goede V; Hallek M
    Lancet; 2015 May; 385(9980):1814-5. PubMed ID: 25882395
    [No Abstract]   [Full Text] [Related]  

  • 14. Micronucleoli in lymphocytes of the peripheral blood of patients suffering from chronic lymphocytic leukemia (B type).
    Smetana K; Subrtová H; Jirásková I; Rosa L
    Sb Lek; 1995; 96(2):69-74. PubMed ID: 8718790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obinutuzumab looks impressive in CLL.
    Cancer Discov; 2014 Apr; 4(4):OF5. PubMed ID: 24706674
    [No Abstract]   [Full Text] [Related]  

  • 16. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
    Knauf WU; Lissichkov T; Aldaoud A; Liberati A; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Tremmel L; Merkle K; Montillo M
    J Clin Oncol; 2009 Sep; 27(26):4378-84. PubMed ID: 19652068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab: new indication. First line treatment of chronic lymphocytic leukaemia: continue to use oral chlorambucil.
    Prescrire Int; 2009 Apr; 18(100):60. PubMed ID: 19585719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine in the treatment of chronic lymphocytic leukemia.
    Knauf W
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term remissions with weekly chlorambucil therapy in patients with intermediate-risk chronic lymphocytic leukaemia.
    Manoharan A
    Br J Haematol; 2002 Sep; 118(4):1193-4. PubMed ID: 12199809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.